Catalyst Event
Cogent Biosciences Inc (COGT) · Other
From KEDI U.S. Next Tech TOP10 Index (KUNTT10)
5/30/2026, 12:00:00 AM
Presentation of detailed positive data from the PEAK Phase 3 trial for bezuclastinib in GIST at the 2026 ASCO Annual Meeting on 2026-05-30, showing a median Progression-Free Survival of 16.5 months vs 9.2 months for the control arm; high impact (≥10%) expected due to pivotal trial results, scheduled.
Korean Translation
2026년 5월 30일 ASCO 연례회의에서 위장관기질종양(GIST) 대상 베주클라스티닙 PEAK 3상 상세 데이터 발표 예정; 중추적 임상 결과에 따른 10% 이상의 주가 영향이 예상됨.
Related Recent Events
Oklo Inc (OKLO) · Earnings Release
Next quarterly earnings release for Q2 2026 is expected.
8/10/2026, 12:00:00 AM
Rocket Lab Corp (RKLB) · Earnings Release
Second Quarter 2026 financial results and conference call are scheduled for 2026-08-06 scheduled.
8/6/2026, 12:00:00 AM
D-Wave Quantum Inc (QBTS) · Earnings Release
Next quarterly earnings report for Q2 2026 is scheduled for August 6, 2026. Low importance is estimated as the scheduling announcement typically results in minimal price movement; scheduled.
8/6/2026, 12:00:00 AM
AeroVironment Inc (AVAV) · Earnings Release
AeroVironment is scheduled to release its Q4 2026 earnings results on June 29, 2026; analysts estimate this date and a Medium importance is estimated as earnings typically drive >5% price volatility scheduled.
6/29/2026, 12:00:00 AM
Cloudflare Inc (NET) · Other
Cloudflare is scheduled to host its 2026 Investor Day at the New York Stock Exchange on 2026-06-09; such events typically result in a ~1-2% price impact, scheduled.
6/9/2026, 12:00:00 AM
AeroVironment Inc (AVAV) · Other
Multiple law firms announced the filing of a securities class action lawsuit against AeroVironment on June 4, 2026, regarding the SCAR program; a Medium importance is estimated as legal risks often impact price by >5%.
6/4/2026, 12:00:00 AM